Anders Berkenstam

Title: Innovations of Anders Berkenstam in Crystalline Forms of Genistein

Introduction

Anders Berkenstam is an inventor based in Sweden, known for his work in the field of pharmaceutical innovations. He has made significant contributions to the development of new crystalline forms of genistein, a compound with potential therapeutic applications.

Latest Patents

Although Anders Berkenstam currently holds no patents, his research focuses on the disclosure of various crystalline forms of genistein. These include crystalline genistein sodium salt dihydrate, crystalline genistein potassium salt dihydrate, crystalline genistein calcium salt, crystalline genistein magnesium salt, crystalline genistein L-lysine salt, crystalline genistein N-methylglucamine salt, crystalline genistein N-ethylglucamine salt, crystalline genistein diethylamine salt, and crystalline genistein monohydrate. His work also encompasses therapeutic compositions that utilize these crystalline forms and methods for treating cancer through the administration of these compounds.

Career Highlights

Anders Berkenstam is associated with Axcentua Pharmaceuticals AB, where he contributes to the advancement of pharmaceutical research. His focus on genistein and its crystalline forms highlights his commitment to developing innovative therapeutic solutions.

Collaborations

Anders collaborates with notable colleagues, including Stefan Rehnmark and Michael-Robin Witt, to further enhance the research and development of pharmaceutical applications.

Conclusion

Anders Berkenstam's work in the field of crystalline forms of genistein represents a significant step forward in pharmaceutical innovation. His contributions may lead to new therapeutic options for cancer treatment, showcasing the importance of research in this area.